Science Applications Intl (NASDAQ:SAIC) underwent analysis by 8 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The following table provides a quick overview ...

In the latest quarter, 5 analysts provided ratings for Science Applications Intl (NASDAQ:SAIC), showcasing a mix of bullish and bearish perspectives. The following table encapsulates their recent ...

Roivant Sciences (NASDAQ:ROIV) has observed the following analyst ratings within the last quarter: These 7 analysts have an average price target of $16.57 versus the current price of Roivant Sciences ...

Exact Sciences Corporation EXAS reported better-than-expected second-quarter financial results on Wednesday. Exact Sciences reported quarterly losses of 9 cents per share, which beat the analyst ...

During the last three months, 4 analysts shared their evaluations of Sight Sciences SGHT, revealing diverse outlooks from bullish to bearish. The following table summarizes their recent ratings, ...

Within the last quarter, Alimera Sciences (NASDAQ:ALIM) has observed the following analyst ratings: These 4 analysts have an average price target of $5.75 versus the current price of Alimera Sciences ...

Last week saw the newest yearly earnings release from Gilead Sciences, Inc. (NASDAQ:GILD), an important milestone in the company's journey to build a stronger business. Gilead Sciences reported in ...

Exact Sciences (EXAS) will likely need to see over $100 a share in a takeover, according to a William Blair analyst, after an earlier report that Abbott Labs (ABT) is in talks to buy the cancer test ...

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Wave Life Sciences (WVE) has drawn fresh attention after regaining full global rights to its ...